The impact of vascular risk factors on erectile function

Drugs of Today

Volumn 41, Issue 1, 2005, Pages 65-74

  Kendirci, Muammer ^a   Nowfar, Sepehr ^a   Hellstrom, Wayne J G ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CHOLESTEROL; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYL RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; VASCULOTROPIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMORBIDITY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENDOTHELIUM LESION; ERECTILE DYSFUNCTION; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOKING; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; IMPOTENCE, VASCULOGENIC; MALE; RISK FACTORS; SMOKING;

EID: 15344341744     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.1.875779     Document Type: Review

References (82)

1. Burnett, A.L. Nitric oxide in the penis: Physiology and pathology. J Urol 1997, 157: 320,
2. NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA 1993, 270: 83.
3. Feldman, H.A., Goldstein, L, Hatzichristou, D.G., Krane, R.J., McKinlay, J.B. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994, 151: 54.
4. Ayta, I.A., McKinlay, J.B., Krane, R.J. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999, 84: 50.
5. Johannes, C.B., Araujo, A.B., Feldman, H.A., Derby, C.A., Kleinman, K.P., McKinlay, J.B. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study. J Urol 2000, 163: 460.
6. Meuleman, E.J. Prevalence of erectile dysfunction: Need for treatment? Int J Impot Res 2002, 14 (Suppl. 1): S22.
7. Chobanian, A.V., Bakris, G.L., Black, H.R. et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289: 2560.
8. Oaks, W.W., Moyer, J.H. Sex and hypertension. Med Asp Hum Sex 1972, 6: 128.
9. Seftel, A.D., Sun, P., Swindle, R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004, 171: 2341.
10. Rosen, R.C., Fisher, W.A., Eardley, I., Niederberger, C., Nadel, A., Sand, M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004, 20: 607.
11. Bivalacqua, T.J., Usta, M.F., Champion, H.C., Kadowitz, P.J., Hellstrom, W.J. Endothelial dysfunction in erectile dysfunction: Role of the endothelium in erectile physiology and disease. J Androl 2003, 24: S17.
12. Chitaley, K., Webb, R.C., Dorrance, A.M., Mills, T.M. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats, Int J Impot Res 2001, 13 (Suppl. 5): S16.
13. Head, R.J. Hypernoradrenergic innervation: Its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 1989, 26: 1.
14. Bivalacqua, T.J., Champion, H.C., Usta, M.F. et al. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci USA 2004, 101: 9121.
15. Toblli, J.E., Stella, I., Inserra, F., Ferder, L, Zeller, F., Mazza, O.N. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens 2000, 13: 686.
16. Burchardt, M., Burchardt, T, Baer, L. et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000, 164: 1188.
17. Park, J.K., Kim, S.Z., Kim, S.H., Park, Y.K., Cho, K.W. Renin angiotensin system in rabbit corpus cavernosum: Functional characterization of angiotensin II receptors. J Urol 1997, 158: 653.
18. Becker, A.J., Uckert, S., Stief, C.G. et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology 2001, 57: 193.
19. Hale, T.M., Okabe, H., Bushfield, T.L., Heaton, J.P., Adams, M.A. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002, 168: 348.
20. Toblli, J.E., Cao, G., DeRosa, G., Di Gennaro, F., Forcada, P. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am J Hypertens 2004, 17: 172.
21. Dusing, R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003, (Suppl. 2): 29.
22. Ushiyama, M., Morita, T., Kuramochi, T., Yagi, S., Katayama, S. Erectile dysfunction in hypertensive rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide. Hypertens Res 2004, 27: 253.
23. Jaffe, A., Chen, Y, Kisch, E.S., Fischel, B., Alon, M., Stern, N. Erectile dysfunction in hypertensive subjects. Assessment of potential determinants. Hypertension 1996, 28: 859.
24. Heaton, J.P., Varrin, S.J. Effects of castration and exogenous testosterone supplementation in an animal model of penile erection. J Urol 1994, 151: 797.
25. Sullivan, M.E., Keoghane, S.R., Miller, M.A. Vascular risk factors and erectile dysfunction. BJU Int 2001, 87: 838.
26. Maatman, T.J., Montague, D.K., Martin, L.M. Erectile dysfunction in men with diabetes mellitus. Urology 1987, 29: 589.
27. Dey, J., Shepherd, M.D. Evaluation and treatment of erectile dysfunction in men with diabetes mellitus. Mayo Clin Proc 2002, 77: 276.
28. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R.J., Cohen, R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989, 20: 1025.
29. Bemelmans, B.L., Meuleman, E.J., Doesburg, W.H., Notermans, S.L., Debruyne, F.M. Erectile dysfunction in diabetic men: The neurological factor revisited. J Urol 1994, 151: 884.
30. Cellek, S., Foxwell, N.A., Moncada, S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003, 52: 2353.
31. Bivalacqua, T.J., Hellstrom, W.J., Kadowitz, P.J., Champion, H.C. Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001, 283: 923.
32. Azadzoi, K.M., Saenz de Tejada, I. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Urol 1992, 148: 1587.
33. Keegan, A., Cotter, M.A., Cameron, N.E. Effecfs of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia 1999, 42: 343.
34. Shimokawa, H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002, 39: 319.
35. Singh, R., Barden, A., Mori, T., Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44: 129.
36. Seftel, A.D., Vaziri, N.D., Ni, Z. et al. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997, 50: 1016.
37. Cartledge, J.J., Eardley, I., Morrison, J.F. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 2001, 87: 402.
38. Usta, M.F., Bivalacqua, T.J., Yang, D.Y. et al. The protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol 2003, 170: 1437.
39. Keegan, A., Cotter, M.A., Cameron, N.E. Corpus cavernosum dysfunction in diabetic rats: Effects of combined alpha-lipoic acid and gamma-linolenic acid treatment. Diabetes Metab Res Rev 2001, 17: 380.
40. Martin, W., McAllister, K.H., Paisley, K. NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of Superoxide dismutase with diethyldithiocarbamate. Neuropharmacology 1994, 33: 1293.
41. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990, 87: 1620.
42. Hirata, K., Kuroda, R., Sakoda, T. et al. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 1995, 25: 180.
43. Cai, H., Harrison, D.G. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000, 87: 840.
44. El-sakka, A.I. Characteristics of erectile dysfunction in Saudi patients, Int J Impot Res 2004, 16: 13.
45. Rosenfeld, M.E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation 1991, 83: 2137.
46. Kugiyama, K., Kerns, S.A., Morrisett, J.D., Roberts, R., Henry, P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990, 344: 160.
47. Rubbo, H., Trostchansky, A., Botti, H., Batthyany, C. Interactions of nitric oxide and peroxynitrite with low-density lipoprotein. Biol Chem 2002, 383: 547.
48. Kim, S.C. Hyperlipidemia and erectile dysfunction. Asian J Androl 2000, 2: 161.
49. Kim, S.C., Kim, I.K., Seo, K.K., Baek, K.J., Lee, M.Y. Involvement of Superoxide radical in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbits. Urol Res 1997, 25: 341.
50. Liao, L., Aw, T.Y., Kvietys, P.R., Granger, D.N. Oxidized LDL-induced microvascular dysfunction. Dependence on oxidation procedure. Arterioscler Thromb Vasc Biol 1995, 15: 2305.
51. Sullivan, M.E., Dashwood, M.R., Thompson, C.S., Mikhailidis, D.P., Morgan, R.J. Down-regulation of endothelin-B receptor sites in cavernosal tissue of hypercholesterolaemic rabbits. Br J Urol 1998, 81: 128.
52. Gholami, S.S., Rogers, R., Chang, J. et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003, 169: 1577.
53. Henry, G.D., Byrne, R., Hunyh, T.T. et al. Intra-cavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: A preliminary study, Int J Impot Res 2000, 12: 334.
54. Junemann, K.P., Aufenanger, J., Konrad, T. et al. The effect of impaired lipid metabolism on the smooth muscle cells of rabbits. Urol Res 1991, 19: 271.
55. Saltzman, E.A., Quay, A.T., Jacobson, J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: A clinical observation. J Urol 2004, 172: 255.
56. CDC. In: Morbidity and Mortality Weekly Review, vol. 52, 2003, 953-56.
57. Bortolotti, A., Parazzini, R, Colli, E., Landoni, M. The epidemiology of erectile dysfunction and its risk factors, Int J Androl 1997, 20: 323.
58. Mannino, D.M., Klevens, R.M., Flanders, W.D. Cigarette smoking: An independent risk factor for impotence? Am J Epidemiol 1994, 140: 1003.
59. Feldman, H.A., Johannes, C.B., Derby, C.A. et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000, 30: 328.
60. Mirone, V., Imbimbo, C., Bortolotti, A. et al. Cigarette smoking as risk factor for erectile dysfunction: Results from an Italian epidemiological study. Eur Urol 2002, 41: 294.
61. McVary, K.T., Carrier, S., Wessells, H. Smoking and erectile dysfunction: evidence based analysis. J Urol 2001, 166: 1624.
62. Rosen, M.P., Greenfield, A.J., Walker, T.G. et al. Cigarette smoking: An independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 1991, 145: 759.
63. Russell, S.T., Khandheria, B.K., Nehra, A. Erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2004, 79: 782.
64. El-Sakka, A.I., Morsy, A.M., Fagih, B.I., Nassar, A.M. Coronary artery risk factors in patients with erectile dysfunction. J Urol 2004, 172: 251.
65. Hirshkowitz, M., Karacan, I., Howell, J.W., Arcasoy, M.O., Williams, R.L. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. Urology 1992, 39: 101.
66. Quay, M.F.A., Perez, M.J., Heatley, M.G. Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract 1998, 4: 23.
67. Jacobs, M.C., Lenders, J.W., Kapma, J.A., Smits, P., Thien, T. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans. Clin Sci (Lond) 1993, 85: 51.
68. Mersdorf, A., Goldsmith, P.C., Diederichs, W. et al. Ultrastructural changes in impotent penile tissue: A comparison of 65 patients. J Urol 1991, 145: 749.
69. Jones, R.W., Rees, R.W., Minhas, S., Ralph, D., Persad, R.A., Jeremy, J.Y. Oxygen free radicals and the penis. Expert Opin Pharmacother 2002, 3: 889.
70. Jeremy, J.Y., Angelini, G.D., Khan, M. et al. Platelets, oxidant stress and erectile dysfunction: An hypothesis. Cardiovasc Res 2000, 46: 50.
71. Juenemann, K.P., Lue, T.F., Luo, J.A., Benowitz, N.L., Abozeid, M., Tanagho, E.A. The effect of cigarette smoking on penile erection. J Urol 1987, 138: 438.
72. Azadzoi, K.M., Goldstein, I. Erectile dysfunction due to atherosclerotic vascular disease: The development of an animal model. J Urol 1992, 147: 1675.
73. Greenstein, A., Chen, J., Miller, H., Matzkin, H., Villa, Y., Braf, Z. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997, 9: 123.
74. Kawanishi, Y, Kimura, K., Nakanishi, R., Numata, A., Taguchi, H. Retinal vascular findings and penile cavernosal artery blood flow. BJU Int 2003, 92: 977.
75. Azadzoi, K.M., Siroky, M.B., Goldstein, I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996, 155: 1795.
76. Speel, T.G., van Langen, H., Meuleman, E.J. The risk of coronary heart disease in men with erectile dysfunction. Eur Urol 2003, 44: 366.
77. Seo, K.K., Yun, H.Y., Kim, H., Kim, S.C. Involvement of endothelial nitric oxide synthase in the impaired endothelium-dependent relaxation of cavernous smooth muscle in hypercholesterolemic rabbit. J Androl 1999, 20: 298.
78. Maytin, M., Leopold, J., Loscalzo, J. Oxidant stress in the vasculature. Curr Atheroscler Rep 1999, 1: 156.
79. Harrison, D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997, 100: 2153.
80. Khan, M.A., Thompson, C.S., Emsley, A.M. et al. The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: New risk factors for angiopathic erectile dysfunction? BJU Int 1999, 84: 720.
81. Yesilli, C., Yaman, O., Anafarta, K. Effect of experimental hypercholesterolemia on cavernosal structures. Urology 2001, 57: 1184.
82. Laufs, U., La Fata, V., Plutzky, J., Liao, J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998, 97: 1129.